Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Oct-19 7:12 PM View:  | Lavelle Erin Chief Operating Officer | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Grant | 11,684 | -- | -- | 265% 4.41K to 16.09K | |
| 24-Oct-19 7:17 PM View: | Redmile Group, LLC Director | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition (change in control) | 8,244,900 | -- | -- | (100%) 8.24M to 0 | |
| 24-Oct-19 7:09 PM View: | Hassler Randal EVP, Pharmaceutical Ops. | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Grant | 14,346 | -- | -- | 264% 5.43K to 19.78K | |
| 24-Oct-19 7:28 PM View: | Streck Paul Chief Medical Officer | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition | 1,390 | $18.00 | $25,020.00 | (100%) 1.39K to 0 | |
| 24-Oct-19 7:07 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition | 21,502 | $18.00 | $387,036.00 | (100%) 21.5K to 0 | |
| 24-Oct-19 6:58 PM View: | Montgomery Alan Bruce Director | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition (change in control) | 9,628 | $18.00 | $173,304.00 | (100%) 9.63K to 0 | |
| 24-Oct-19 7:03 PM View: | Siegall Clay B Director | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition (change in control) | 31,714 | $18.00 | $570,852.00 | (100%) 31.71K to 0 | |
| 24-Oct-19 7:05 PM View: | Yarno Wendy L Director | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition (change in control) | 5,000 | $18.00 | $90,000.00 | (100%) 5.0K to 0 | |
| 24-Oct-19 7:10 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition (change in control) | 27,677 | $18.00 | $498,186.00 | (100%) 27.68K to 0 | |
| 24-Oct-19 7:09 PM View: | Hassler Randal EVP, Pharmaceutical Ops. | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition | 19,780 | $18.00 | $356,040.00 | (100%) 19.78K to 0 | |
| 24-Oct-19 7:07 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Grant | 16,230 | -- | -- | 308% 5.27K to 21.5K | |
| 24-Oct-19 7:12 PM View: | Lavelle Erin Chief Operating Officer | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Disposition (change in control) | 16,092 | $18.00 | $289,656.00 | (100%) 16.09K to 0 | |
| 24-Oct-19 7:10 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 22-Oct-19 | Grant | 15,619 | -- | -- | 130% 12.06K to 27.68K | |
| 24-Oct-19 7:28 PM View: | Streck Paul Chief Medical Officer | Alder Biopharmaceuticals Inc (ALDR) | 11-Oct-19 | Grant | 1,390 | $9.20 | $12,788.00 | 100% 0 to 1.39K | |
| 24-Oct-19 7:10 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 11-Oct-19 | Grant | 904 | $9.20 | $8,316.80 | 8% 11.15K to 12.06K | |
| 18-Sep-19 4:45 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 16-Sep-19 | Option Exercise | 32,728 | $4.15 | $135,902.00 | 621% 5.27K to 38.0K | |
| 18-Sep-19 4:45 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 16-Sep-19 | Planned Private Option Sale | 32,728 | $18.44 | $603,504.00 | (86%) 38.0K to 5.27K | |
| 24-Oct-19 7:10 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 31-May-19 | Grant | 1,345 | $9.20 | $12,370.00 | 14% 9.81K to 11.15K | |
| 25-Apr-19 6:55 PM View: | Hassler Randal EVP, Pharmaceutical Ops. | Alder Biopharmaceuticals Inc (ALDR) | 25-Apr-19 | Market Sale (Planned) | 1,738 | $13.85 | $24,067.00 | (24%) 7.17K to 5.43K | |
| 25-Apr-19 6:51 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 25-Apr-19 | Disposition | 4,847 | $13.73 | $66,525.60 | (48%) 10.12K to 5.27K | |
| 25-Apr-19 6:43 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 25-Apr-19 | Market Sale (Planned) | 1,897 | $13.85 | $26,280.80 | (16%) 11.71K to 9.81K | |
| 25-Apr-19 6:49 PM View: | Lavelle Erin Chief Operating Officer | Alder Biopharmaceuticals Inc (ALDR) | 25-Apr-19 | Market Sale (Planned) | 1,434 | $13.67 | $19,599.30 | (25%) 5.84K to 4.41K | |
| 25-Apr-19 6:53 PM View: | Benedict Larry EVP and PAO | Alder Biopharmaceuticals Inc (ALDR) | 25-Apr-19 | Market Sale (Planned) | 1,734 | $13.65 | $23,662.20 | (4%) 41.46K to 39.73K | |
| 25-Apr-19 6:51 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 23-Apr-19 | Grant | 9,288 | -- | -- | 1118% 0.83K to 10.12K | |
| 25-Apr-19 6:53 PM View: | Benedict Larry EVP and PAO | Alder Biopharmaceuticals Inc (ALDR) | 23-Apr-19 | Grant | 7,055 | -- | -- | 21% 34.41K to 41.46K | |
| 25-Apr-19 6:49 PM View: | Lavelle Erin Chief Operating Officer | Alder Biopharmaceuticals Inc (ALDR) | 23-Apr-19 | Grant | 5,842 | -- | -- | 100% 0 to 5.84K | |
| 25-Apr-19 6:43 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 23-Apr-19 | Grant | 7,810 | -- | -- | 200% 3.9K to 11.71K | |
| 25-Apr-19 6:55 PM View: | Hassler Randal EVP, Pharmaceutical Ops. | Alder Biopharmaceuticals Inc (ALDR) | 23-Apr-19 | Grant | 7,172 | -- | -- | 100% 0 to 7.17K | |
| 06-Mar-19 4:24 PM View: | Redmile Group, LLC Director | Alder Biopharmaceuticals Inc (ALDR) | 04-Mar-19 | Grant | 1,739,130 | $11.50 | $20,000,000.00 | 27% 6.51M to 8.24M | 11% |
| 04-Dec-18 6:39 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 03-Dec-18 | Option Exercise | 5,044 | $0.99 | $4,993.56 | 607% 0.83K to 5.88K | |
| 04-Dec-18 6:39 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 03-Dec-18 | Market Option Sale (Planned) | 5,044 | $13.84 | $69,826.10 | (86%) 5.88K to 0.83K | (3%) |
| 08-Feb-19 4:41 PM View: | Benedict Larry EVP and PAO | Alder Biopharmaceuticals Inc (ALDR) | 30-Nov-18 | Grant | 954 | $9.35 | $8,919.90 | 3% 33.45K to 34.41K | |
| 08-Feb-19 4:47 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 30-Nov-18 | Grant | 487 | $9.35 | $4,553.45 | < 1% 243.69K to 244.18K | |
| 08-Feb-19 4:43 PM View: | Bucher James B EVP & General Counsel | Alder Biopharmaceuticals Inc (ALDR) | 30-Nov-18 | Grant | 273 | $9.35 | $2,552.55 | 8% 3.62K to 3.9K | |
| 05-Nov-18 5:43 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 01-Nov-18 | Option Exercise | 25,002 | $9.12 | $227,954.00 | 10% 243.69K to 268.69K | |
| 05-Nov-18 5:43 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 01-Nov-18 | Market Option Sale (Planned) | 25,002 | $13.42 | $335,589.00 | (9%) 268.69K to 243.69K | (7%) |
| 05-Nov-18 5:47 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 01-Nov-18 | Option Exercise | 5,040 | $0.99 | $4,989.60 | 606% 0.83K to 5.87K | |
| 05-Nov-18 5:47 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 01-Nov-18 | Market Option Sale (Planned) | 5,040 | $13.42 | $67,636.80 | (86%) 5.87K to 0.83K | (7%) |
| 03-Oct-18 6:31 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 01-Oct-18 | Option Exercise | 24,999 | $4.36 | $109,108.00 | 10% 243.69K to 268.69K | |
| 03-Oct-18 6:31 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 01-Oct-18 | Market Option Sale (Planned) | 24,999 | $15.44 | $386,006.00 | (9%) 268.69K to 243.69K | 7% |
| 03-Oct-18 6:33 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 01-Oct-18 | Option Exercise | 5,040 | $0.99 | $4,989.60 | 606% 0.83K to 5.87K | |
| 03-Oct-18 6:33 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 01-Oct-18 | Market Option Sale (Planned) | 5,040 | $15.54 | $78,329.40 | (86%) 5.87K to 0.83K | 8% |
| 06-Sep-18 5:08 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 04-Sep-18 | Option Exercise | 5,040 | $0.99 | $4,989.60 | 606% 0.83K to 5.87K | |
| 06-Sep-18 5:08 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 04-Sep-18 | Market Option Sale (Planned) | 5,040 | $18.00 | $90,698.80 | (86%) 5.87K to 0.83K | 20% |
| 06-Sep-18 5:05 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 04-Sep-18 | Option Exercise | 24,999 | $3.46 | $86,621.50 | 10% 243.69K to 268.69K | |
| 06-Sep-18 5:05 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 04-Sep-18 | Market Option Sale (Planned) | 24,999 | $17.99 | $449,680.00 | (9%) 268.69K to 243.69K | 20% |
| 02-Aug-18 5:40 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 01-Aug-18 | Option Exercise | 24,999 | $3.46 | $86,621.50 | 10% 243.69K to 268.69K | |
| 02-Aug-18 5:40 PM View: | Latham John A Chief Scientific Officer | Alder Biopharmaceuticals Inc (ALDR) | 01-Aug-18 | Market Option Sale (Planned) | 24,999 | $19.55 | $488,768.00 | (9%) 268.69K to 243.69K | 27% |
| 02-Aug-18 5:48 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 01-Aug-18 | Option Exercise | 5,040 | $0.99 | $4,989.60 | 606% 0.83K to 5.87K | |
| 02-Aug-18 5:48 PM View: | Smith Jeffrey T L Managing Director | Alder Biopharmaceuticals Inc (ALDR) | 01-Aug-18 | Market Option Sale (Planned) | 5,040 | $19.54 | $98,489.00 | (86%) 5.87K to 0.83K | 27% |
